comparemela.com

Latest Breaking News On - Vanda pharmaceutical hetlioz - Page 1 : comparemela.com

GlobalData : Dual orexin receptor antagonists to drive insomnia market across 7MM to $4 1 billion in 2032, says GlobalData -December 26, 2023 at 08:15 am EST

26 Dec, 2023 Dual orexin receptor antagonists to drive insomnia market across 7MM to $4.1 billion in 2032, says GlobalData Share .

United kingdomIdorsia quviviqMerck belsomraChristie wongEisai dayvigoMarket opportunity assessmentClinical trialsUnmet needsPharma analystVanda pharmaceutical hetliozTaisho pharmaceuticalImbrium therapeutics

The Unmet Need for New Insomnia Drugs

While DORAs are safer than Z-drugs, they fall short in terms of efficacy, leaving an unmet need for insomnia drug therapies.

Idorsia quviviqTakeda rozeremEisai dayvigoChristie wongMerck belsomraDrug administrationVanda pharmaceuticalsBenzodiazepine likez drugsVanda pharmaceutical hetliozTaisho pharmaceutical

GlobalData : Insomnia treatment market faces need for innovation as Z-drugs show limitations, says GlobalData -October 04, 2023 at 08:36 am EDT

04 Oct, 2023 Insomnia treatment market faces need for innovation as Z-drugs show limitations, says GlobalData Share Print.

Idorsia quviviqMerck belsomraEisai dayvigoChristie wongTakeda rozeremVanda pharmaceuticalsBenzodiazepine likez drugsPharma analystVanda pharmaceutical hetliozTaisho pharmaceutical

vimarsana © 2020. All Rights Reserved.